Gtcr Investment Xi Llc Sells 12,000,000 Shares of Sotera Health (NASDAQ:SHC) Stock

Sotera Health Company (NASDAQ:SHC) Director Gtcr Investment Xi Llc sold 12,000,000 shares of Sotera Health stock in a transaction on Monday, November 10th. The shares were sold at an average price of $15.65, for a total transaction of $187,800,000.00. Following the completion of the transaction, the director directly owned 29,215,301 shares of the company’s stock, valued at $457,219,460.65. The trade was a 29.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Gtcr Investment Xi Llc also recently made the following trade(s):

• On Friday, September 5th, Gtcr Investment Xi Llc sold 8,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.11, for a total transaction of $120,880,000.00.

Sotera Health Price Performance

SHC stock traded up $0.12 during trading on Wednesday, hitting $16.25. The stock had a trading volume of 5,110,059 shares, compared to its average volume of 1,503,509. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18. The company’s 50-day moving average price is $16.09 and its two-hundred day moving average price is $13.87. The stock has a market capitalization of $4.62 billion, a P/E ratio of 85.53 and a beta of 1.82. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $17.78.

Hedge Funds Weigh In On Sotera Health

Several institutional investors have recently modified their holdings of SHC. Vanguard Group Inc. lifted its position in Sotera Health by 10.5% in the third quarter. Vanguard Group Inc. now owns 16,471,792 shares of the company’s stock worth $259,101,000 after purchasing an additional 1,561,282 shares during the period. Sculptor Capital LP raised its stake in shares of Sotera Health by 27.2% in the 2nd quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock valued at $127,880,000 after acquiring an additional 2,462,489 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Sotera Health by 5.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 8,045,502 shares of the company’s stock worth $93,811,000 after buying an additional 450,761 shares during the last quarter. TPG GP A LLC bought a new stake in shares of Sotera Health in the 1st quarter worth approximately $79,126,000. Finally, MIG Capital LLC grew its stake in shares of Sotera Health by 3.3% in the 2nd quarter. MIG Capital LLC now owns 5,282,339 shares of the company’s stock valued at $58,740,000 after purchasing an additional 168,388 shares during the period. Institutional investors own 91.03% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on SHC. JPMorgan Chase & Co. lifted their price target on shares of Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Piper Sandler upped their target price on shares of Sotera Health from $15.00 to $17.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Sotera Health in a research report on Friday, October 31st. Barclays lifted their price objective on shares of Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Finally, Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Three analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.40.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.